モノクローナル抗体市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00026641
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 163
Buy Now

モノクローナル抗体市場は、2021 年の 1,110.1 億米ドルから 2028 年までに 2,430.5 億米ドルに達すると予測されています。 2021 年から 2028 年にかけて CAGR 11.8% で成長すると予想されます。



がんやその他の慢性疾患の有病率の増加、およびさまざまな地域での COVID-19 症例の大幅な増加。地域は、市場の成長を後押しする重要な要因です。世界がん研究基金と米国がん研究所によると、2020 年には、男性で 930 万件、女性で 880 万件を含む、約 1,810 万件のがん症例が記録されました。さまざまな種類のがんの治療におけるモノクローナル抗体の使用は、まだ第 2 相および第 3 相の試験段階にあります。



戦略的洞察



北米は、2021 年から 2028 年の間、モノクローナル抗体市場での優位性を維持する可能性があります。米国は、この地域で最大の市場シェアを保持しており、予測期間中も市場の支配的な株主であり続けると予想されます。 Globocan 2020 によって発表された統計によると、米国では約 1,806,590 人の新たな癌の症例が診断され、約 606,520 人がこの病気で死亡しました。米国商務省の報告によると、米国立標準技術研究所 (NIST) は、国立バイオ医薬品製造技術革新研究所に 1 億 5,300 万米ドルの資金提供を発表しました。さらに、FDA は、COVID-19 が蔓延する中、モノクローナル抗体の開発に対するサポートを拡大しています。



モノクローナル抗体市場の有利な地域



< h3>市場の洞察

がんやその他の慢性疾患の有病率の大幅な上昇が市場の成長を促進



米国がん協会のレポートによると、2019 年 1 月の時点で、がんの病歴を持つ約 1,690 万人が米国に居住していました。そのため、がんやその他の慢性疾患の有病率の増加に伴い、モノクローナル抗体 (mAB) などの生物製剤の需要も急増しています。多くの治療レジメンと費用対効果の高い治療の主要な構成要素である生物製剤は、がん治療において重要な役割を果たしています。



情報源に基づく洞察



モノクローナル抗体市場で事業を展開している企業は、製品革新戦略を採用して、世界中で進化する顧客の需要に対応しています。これにより、グローバル市場でブランド名を維持することもできます。



モノクローナル抗体市場 - セグメンテーション



ソースに基づいて、モノクローナル抗体市場は、ヒト、ヒト化、キメラ、およびマウスに分割されます。製造方法によって、市場はインビトロとインビボに分割されます。モノクローナル抗体市場は、徴候によって、がん、自己免疫疾患、感染症、炎症性疾患、微生物疾患などにさらに分割されます。アプリケーションによって、市場は治療アプリケーション、診断アプリケーション、および研究アプリケーションとしてサブセグメント化されます。さらに、エンドユーザーに基づいて、市場は病院、その他、および研究機関に分割されます..



モノクローナル抗体市場 - 地域別



  1. 北米

    1. 米国

    2. カナダ

    3. メキシコ



  2. ヨーロッパ

    1. フランス

    2. ドイツ

    3. イタリア

    4. 英国

    5. スペイン

    6. その他のヨーロッパ




  3. アジア太平洋 (APAC)

    1. 中国

    2. インド

    3. < li>韓国
    4. 日本

    5. オーストラリア

    6. その他のAPAC




  4. 中東およびアフリカ (MEA)

    1. 南アフリカ

    2. サウジアラビア

    3. UAE

    4. MEA の残り




  5. 南部と中部アメリカ (詐欺)

    1. ブラジル

    2. アルゼンチン

    3. 残りの詐欺

    < TIP>



会社概要




  1. Novartis AG
  2. Pfizer Inc.

  3. GlaxoSmithKline plc

  4. Amgen, Inc.

  5. 第一三共株式会社、限定

  6. F. Hoffmann-La Roche AG

  7. AstraZeneca

  8. Elli Lily and Company

  9. Bayer AG

  10. < li>Bristol-Myers Squibb Company






Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional market scenario of the monoclonal antibodies market?

Global monoclonal antibodies market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for monoclonal antibodies market. The US is estimated to hold the largest share in the monoclonal antibodies market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for monoclonal antibodies accounting fastest growth of the region during the coming years.

Who are the key players in the monoclonal antibodies market?

Novartis AG, Pfizer, Inc., GlaxoSmithKline Plc, Amgen, Inc., Daiichi Sankyo Company, Limited, F.Hoffmann-La Roche AG, AstraZeneca, Elli Lilly and Company, Bayer AG, Bristol-Myers Squibb Company are among the leading companies operating in the global monoclonal antibodies market

Which production method segment held the largest revenue (US$ Mn) in the monoclonal antibodies market?

The in vitro segment dominated the global monoclonal antibodies market and accounted for the largest revenue of 75,044.50 Mn in 2021.

What is meant by the monoclonal antibodies market?

Food and Drug Administration (FDA) defines monoclonal antibodies as immunoglobulin molecules that are secreted from a population of identical cells. They are homogenous in structure and binding specificity. These are used as multifunctional components for the immune system. They facilitate numerous cellular and humoral reactions to a variety of antigens, which include host and foreign substances.

What are the driving factors for the monoclonal antibodies market across the globe?

Significant rise in the cancer and chronic diseases is one of the most significant factors responsible for the overall market growth.

Which segment led the monoclonal antibodies market?

Based on source, human segment took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

The List of Companies - Monoclonal Antibody Market

  1. Novartis AG
  2. Pfizer Inc.
  3. GlaxoSmithKline plc
  4. Amgen, Inc
  5. Daiichi Sankyo Company, Limited
  6. F. Hoffmann-La Roche AG
  7. AstraZeneca
  8. Elli Lilly and Company
  9. Bayer AG
  10. Bristol-Myers Squibb Company

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports